Citations

Showing 10 of 108104 citations.

Final results of a phase Ib study of isatuximab (ISA) plus pomalidomide (Pom) and dexamethasone (dex) in relapsed/refractory multiple myeloma (RRMM).
Richardson, Paul G. , Usmani, Saad Zafar, Bensinger, William, Dubin, Franck , Liu, Qianying , Vitse, Olivier , Mıkhael, Joseph , Richardson, Paul Gerard Guy , Usmani, Saad Zafar, Raje, Noopur , Anderson, Kenneth C.

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 8038-8038

10.1200/jco.2018.36.15_suppl.8038 Get It

Overall survival of intensive care unit patients with hematological malignancies: A 5-year retrospective study.
Quintero, Agamenón, Racedo, Jorge , Fernández, M. , Nates, Joseph L. , Aguilera, Jesus Vera, Pérez, H., Quintero, Aaron

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: e19560-e19560

10.1200/jco.2018.36.15_suppl.e19560 Get It

Rituximab maintenance for mantle cell lymphoma: A meta-analysis.
Almader‐Douglas, Diana , Reeder, Craig B. , Jain, Tania , Jain, Tania , Hilal, Talal , Wang, Zhen , Rosenthal, Allison

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: e19557-e19557

10.1200/jco.2018.36.15_suppl.e19557 Get It

Current trends and inpatient outcomes of venous thromboembolism-related admissions among patients with diffuse large B-cell lymphoma: A Nationwide Inpatient Sample Database analysis.
Gonzalez, Xavier Alberto Andrade, Bayne, Harry Eduardo Fuentes, Mann, Hashim , Hernandez, Andres Mendez, Tafur, Alfonso , Leon‐Ferre, Roberto A.

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: e19546-e19546

10.1200/jco.2018.36.15_suppl.e19546 Get It

Self-stated and actual practice patterns of general medical oncologists (MO) regarding the use of predictive biomarkers to guide treatment for patients (pts) with chronic lymphocytic leukemia (CLL).
Escalón, Maricer P. , Wierda, William G. , LaCasce, Ann S. , Harwin, William N., Kelly, Gloria, Miller, K., Paley, Douglas, Nelson, Joe, Ziel, Kathryn, Love, Neil, Wierda, William G. , Jevremović, Dragan , Nelson, Joe

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: e19510-e19510

10.1200/jco.2018.36.15_suppl.e19510 Get It

A pilot study evaluating the impact of hospital hospitality houses (HHH) programs on the quality of life and mood of patients and their caregivers following hematopoietic stem cell transplant (HCT).
Torres, Maria Emma, Colón‐Otero, Gerardo

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: e19500-e19500

10.1200/jco.2018.36.15_suppl.e19500 Get It

Predictors of long-term survival in newly diagnosed multiple myeloma (NDMM) patients (pts) enrolled in the Connect MM registry.
Gasparetto, Cristina, Rifkin, Robert M. , Terebelo, Howard R. , Toomey, Kathleen, Durie, Brian G.M. , Narang, Mohit , Flick, E. Dawn, Kotey, Stanley, Srinivasan, Shankar , Kitali, Amani, Agarwal, Amit , Abonour, Rafat , Gasparetto, Cristina , Hardin, James W. , Jagannath, Sundar , Wagner, Lynne I. , Ailawadhi, Sikander

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 8037-8037

10.1200/jco.2018.36.15_suppl.8037 Get It

Prognostic value of minimal residual disease and polyclonal plasma cells in myeloma patients achieving a complete response to therapy.
Tschautscher, Marcella , Lacy, Martha Q. , Hayman, Suzanne R. , Hwa, Yi L. , Fonder, Amie , Hobbs, Miriam, Zeldenrust, Steven R., Lust, John A., Kapoor, Prashant , Kourelis, Taxiarchis , Warsame, Rahma , Kyle, Robert A. , Kumar, Shaji , Rajkumar, S. Vincent , Buadi, Francis K. , Gertz, Morie A. , Dispenzieri, Angela , Leung, Nelson , Go, Ronald S. , Gonsalves, Wilson I.

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 8030-8030

10.1200/jco.2018.36.15_suppl.8030 Get It

bb2121 anti-BCMA CAR T-cell therapy in patients with relapsed/refractory multiple myeloma: Updated results from a multicenter phase I study.
Munshi, Nikhil C. , Liedtke, Michaela , Madduri, Deepu , Turka, Ashley, Lam, Lyh Ping, Morgan, Richard A. , Quigley, T. B. , Massaro, Monica, Hege, Kristen , Raje, Noopur , Berdeja, Jesús G. , Lin, Yi , Siegel, David S. , Jagannath, Sundar , Rosenblatt, Jacalyn , Maus, Marcela V , Quigley, Travis, Petrocca, Fabio , Kochenderfer, James N.

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 8007-8007

10.1200/jco.2018.36.15_suppl.8007 Get It

Phase 2 study of venetoclax plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma.
Stadtmauer, Edward A. , Monohan, Gregory, Kovacsovics, Tibor , Burwick, Nicholas , Mobasher, Mehrdad, Freise, Kevin J. , Munasinghe, Wijith, Cordero, Jaclyn, Morris, Lura, Maciag, Paulo , Bueno, Orlando F. , Kumar, Shaji , Costa, Luciano J. , Morgan, Gareth J. , Jakubowiak, Andrzej , Ross, Jeremy A. , Pesko, John Carl

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 8004-8004

10.1200/jco.2018.36.15_suppl.8004 Get It